meta_pixel
Tapesearch Logo
Log in
Skin Anarchy

The Exosome Question with David Panter of RadiantXO

Skin Anarchy

Ekta et al.

Fashion & Beauty, News, Entertainment News, Education, Arts, Self-improvement

4.5101 Ratings

🗓️ 4 June 2026

⏱️ 34 minutes

🧾️ Download transcript

Summary

Send us Fan Mail In this episode of Skin Anarchy, Dr. Ekta Yadav sits down with David Panter, founder and CEO of RadiantXO, for a conversation that cuts through one of the most talked-about—and misunderstood—areas of modern skincare: regenerative science. As exosomes and extracellular vesicles continue to dominate industry conversations, this episode explores what these technologies actually are, why they matter, and how consumers can separate scientific substance from marketing noise. At the...

Transcript

Click on a timestamp to play from that location

0:39.3

Hey guys, welcome back to Skin Anarchy. Today's a very special episode because we're going to be diving deep into the world of exosomes. I know that you guys come to us a lot of times to learn more about the regenerative side of skincare. And I think exosomes and extracellular vesicles are definitely at the forefront right now. A lot of buzzes being created in the space. And so I'm really excited to kind of dive in. Without further ado, please welcome David Panter, who is the CEO and founder of Radiant XL. Welcome, David. I'm so excited to chat with you today. Well, good afternoon and thank you so much. Excited to be on your show. Yeah, I really want to dive in, you know, because exosomes that are incredibly interesting space right now. And I know a lot of consumers have so many questions around them. So I'd love to start with, you know, understanding exosomes, understanding the science.

0:44.3

Let's start with the fundamentals because I think even amongst the professionals out there,

0:48.3

there's a lot of confusion.

0:50.3

So if you could kind of get us started.

0:51.3

Well, with the marketization of what's going on in the world of stem cells and exosomes,

0:56.0

I understand that.

0:57.6

And so we actually had to wait through that ourselves.

1:01.6

And it's because of my background, being in the medical industry since 2014,

1:06.6

and owning pharmacies and owning laboratories,

1:10.4

it's through those relationships that I was able to be introduced to this from a manufacturing

1:15.7

because it's a 13-year research project that was brought into the medical field by a SEC medical

1:23.4

university.

1:24.3

So it's got a lot of science behind it.

1:26.4

And we were on the tip of the spear and now it's

1:28.4

been commercialized so much. So I do understand those concerns and the confusion that people are

1:34.4

experiencing, right? Yeah. I mean, it is definitely a confusing space because there's a lot of

1:39.6

terms being thrown around. And I think a lot of times people don't know how to put everything into

1:44.1

context, you know, in terms of like what matters and what do I need to understand. I think a lot of

1:48.8

times what gets lost is this idea of like, you know, what are they actually doing? Like, what are

1:54.4

exosomes doing? So an exosome is, for starters, our exosomes are sole source from a single embiblical cord. They're human, a human umbilical cord that is, for starters, our exosomes are sole source from a single embiblical cord.

2:02.7

They're human, a human imbilical cord that is stringently tested.

2:06.6

They are actually stem cells where the exosomes are extracted from those.

...

Transcript will be available on the free plan in 25 days. Upgrade to see the full transcript now.

Disclaimer: The podcast and artwork embedded on this page are from Ekta et al., and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Ekta et al. and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.